ABCA8 | ATP-binding cassette, sub-family A (ABC1), member 8 | Predicted membrane proteins Transporters
| | | | | Mixed |
ABCD3 | ATP-binding cassette, sub-family D (ALD), member 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
ACKR2 | Atypical chemokine receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
ACSL3 | Acyl-CoA synthetase long-chain family member 3 | Cancer-related genes Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
ACSL5 | Acyl-CoA synthetase long-chain family member 5 | Enzymes Mitochondrial proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
AGTRAP | Angiotensin II receptor-associated protein | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
APH1A | APH1A gamma secretase subunit | Predicted membrane proteins
| | | | | Expressed in all |
AQP1 | Aquaporin 1 (Colton blood group) | Blood group antigen proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ARL6IP5 | ADP-ribosylation-like factor 6 interacting protein 5 | Predicted membrane proteins
| | | | | Expressed in all |
ATP1A1 | ATPase, Na+/K+ transporting, alpha 1 polypeptide | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP2A3 | ATPase, Ca++ transporting, ubiquitous | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP2C1 | ATPase, Ca++ transporting, type 2C, member 1 | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
BCAP29 | B-cell receptor-associated protein 29 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
BCAP31 | B-cell receptor-associated protein 31 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
BSCL2 | Berardinelli-Seip congenital lipodystrophy 2 (seipin) | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
BVES | Blood vessel epicardial substance | Predicted membrane proteins
| | | | | Tissue enhanced |
CD151 | CD151 molecule (Raph blood group) | Blood group antigen proteins CD markers Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
CD37 | CD37 molecule | CD markers Predicted membrane proteins
| | | | | Expressed in all |
CD63 | CD63 molecule | CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CD81 | CD81 molecule | CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
CD82 | CD82 molecule | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CD9 | CD9 molecule | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
CLCC1 | Chloride channel CLIC-like 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
CLCN7 | Chloride channel, voltage-sensitive 7 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
CLDN1 | Claudin 1 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CLDN10 | Claudin 10 | Predicted membrane proteins
| | | | | Tissue enhanced |
CLDN11 | Claudin 11 | Predicted membrane proteins
| | | | | Tissue enhanced |
CLDN18 | Claudin 18 | Predicted membrane proteins
| | | | | Group enriched |
CLDN4 | Claudin 4 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
CLDN7 | Claudin 7 | Cancer-related genes Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Mixed |
CLN6 | Ceroid-lipofuscinosis, neuronal 6, late infantile, variant | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
CMTM4 | CKLF-like MARVEL transmembrane domain containing 4 | Predicted membrane proteins
| | | | | Expressed in all |
CMTM5 | CKLF-like MARVEL transmembrane domain containing 5 | Predicted membrane proteins
| | | | | Tissue enriched |
CXCR2 | Chemokine (C-X-C motif) receptor 2 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
CYBA | Cytochrome b-245, alpha polypeptide | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
CYP3A4 | Cytochrome P450, family 3, subfamily A, polypeptide 4 | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
DAD1 | Defender against cell death 1 | Cancer-related genes Enzymes Predicted membrane proteins
| | | | | Expressed in all |
DARC | Duffy blood group, atypical chemokine receptor | Blood group antigen proteins CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
DERL2 | Derlin 2 | Predicted membrane proteins
| | | | | Expressed in all |
DHCR7 | 7-dehydrocholesterol reductase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
DRAM1 | DNA-damage regulated autophagy modulator 1 | Predicted membrane proteins
| | | | | Expressed in all |
EDNRA | Endothelin receptor type A | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
EI24 | Etoposide induced 2.4 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ELOVL6 | ELOVL fatty acid elongase 6 | Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Mixed |
ELTD1 | EGF, latrophilin and seven transmembrane domain containing 1 | G-protein coupled receptors Plasma proteins Predicted membrane proteins Transporters
| | | | | Mixed |
ENDOD1 | Endonuclease domain containing 1 | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
FADS1 | Fatty acid desaturase 1 | FDA approved drug targets Predicted membrane proteins
| | | | | Expressed in all |
FAIM2 | Fas apoptotic inhibitory molecule 2 | Predicted membrane proteins
| | | | | Group enriched |
GLP2R | Glucagon-like peptide 2 receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
GOLT1B | Golgi transport 1B | Predicted membrane proteins
| | | | | Expressed in all |